| Sajjad Minhas, MD | |
|
515 N Mesa Dr, Mesa, AZ 85201-5914 | |
| (480) 844-6285 | |
| Not Available |
| Full Name | Sajjad Minhas |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 36 Years |
| Location | 515 N Mesa Dr, Mesa, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205996410 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 22539 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dignity Health Arizona General Hospital | Mesa, AZ | Hospital |
| St Luke's Medical Center | Phoenix, AZ | Hospital |
| Dignity Health - Arizona General Hospital | Laveen, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Phoenix Emergency Physicians Llc | 7012238934 | 18 |
| Tec Emergency Physicians Of Arizona, Llc | 6204256084 | 111 |
News Archive
Scientists have identified a new, highly conserved molecular target on the influenza A virus and demonstrated that human antibodies against this target are protective in animal models of seasonal and highly-pathogenic avian influenza. The work was conducted by researchers at Theraclone Sciences, with collaborators at University of Wisconsin-Madison, University of Tokyo and Johns Hopkins University; and is reported this week in the online Early Edition of the Proceedings of the National Academy of Sciences.
NicOx S.A. announced the presentation of detailed 26-week efficacy, safety and tolerability data from the second pivotal phase 3 study for naproxcinod (the 302 study) yesterday, at the American College of Rheumatology (ACR) and Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting in Philadelphia, Pennsylvania.
Novimmune SA announces that patients diagnosed with hemophagocytic lymphohistiocytosis (HLH), and who are participating in the company's ongoing clinical trial of its NI-0501 monoclonal antibody, will now be able to be treated with the drug without having to first fail conventional treatments.
Dizziness is one of the most common medical complaints affecting older adults, with 10-20 percent of such complaints resulting from Benign Paroxysmal Positional Vertigo (BPPV). Many research studies have stated that without medical treatment, some 30 percent of BPPV patients will recover on their own. Now, a new evidence-based review has found that a single ten minute in-office treatment, based on a series of head and body turns, is highly effective in resolving this disorder, with an overall effectiveness of 70-80 percent.
› Verified 3 days ago
| Entity Name | Steward Emergency Physicians Of Arizona Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558827998 PECOS PAC ID: 4486995420 Enrollment ID: O20190401001375 |
News Archive
Scientists have identified a new, highly conserved molecular target on the influenza A virus and demonstrated that human antibodies against this target are protective in animal models of seasonal and highly-pathogenic avian influenza. The work was conducted by researchers at Theraclone Sciences, with collaborators at University of Wisconsin-Madison, University of Tokyo and Johns Hopkins University; and is reported this week in the online Early Edition of the Proceedings of the National Academy of Sciences.
NicOx S.A. announced the presentation of detailed 26-week efficacy, safety and tolerability data from the second pivotal phase 3 study for naproxcinod (the 302 study) yesterday, at the American College of Rheumatology (ACR) and Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting in Philadelphia, Pennsylvania.
Novimmune SA announces that patients diagnosed with hemophagocytic lymphohistiocytosis (HLH), and who are participating in the company's ongoing clinical trial of its NI-0501 monoclonal antibody, will now be able to be treated with the drug without having to first fail conventional treatments.
Dizziness is one of the most common medical complaints affecting older adults, with 10-20 percent of such complaints resulting from Benign Paroxysmal Positional Vertigo (BPPV). Many research studies have stated that without medical treatment, some 30 percent of BPPV patients will recover on their own. Now, a new evidence-based review has found that a single ten minute in-office treatment, based on a series of head and body turns, is highly effective in resolving this disorder, with an overall effectiveness of 70-80 percent.
› Verified 3 days ago
| Entity Name | Tec Emergency Physicians Of Arizona, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245772870 PECOS PAC ID: 6204256084 Enrollment ID: O20201016000157 |
News Archive
Scientists have identified a new, highly conserved molecular target on the influenza A virus and demonstrated that human antibodies against this target are protective in animal models of seasonal and highly-pathogenic avian influenza. The work was conducted by researchers at Theraclone Sciences, with collaborators at University of Wisconsin-Madison, University of Tokyo and Johns Hopkins University; and is reported this week in the online Early Edition of the Proceedings of the National Academy of Sciences.
NicOx S.A. announced the presentation of detailed 26-week efficacy, safety and tolerability data from the second pivotal phase 3 study for naproxcinod (the 302 study) yesterday, at the American College of Rheumatology (ACR) and Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting in Philadelphia, Pennsylvania.
Novimmune SA announces that patients diagnosed with hemophagocytic lymphohistiocytosis (HLH), and who are participating in the company's ongoing clinical trial of its NI-0501 monoclonal antibody, will now be able to be treated with the drug without having to first fail conventional treatments.
Dizziness is one of the most common medical complaints affecting older adults, with 10-20 percent of such complaints resulting from Benign Paroxysmal Positional Vertigo (BPPV). Many research studies have stated that without medical treatment, some 30 percent of BPPV patients will recover on their own. Now, a new evidence-based review has found that a single ten minute in-office treatment, based on a series of head and body turns, is highly effective in resolving this disorder, with an overall effectiveness of 70-80 percent.
› Verified 3 days ago
| Entity Name | Phoenix Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366156259 PECOS PAC ID: 7012238934 Enrollment ID: O20230403000159 |
News Archive
Scientists have identified a new, highly conserved molecular target on the influenza A virus and demonstrated that human antibodies against this target are protective in animal models of seasonal and highly-pathogenic avian influenza. The work was conducted by researchers at Theraclone Sciences, with collaborators at University of Wisconsin-Madison, University of Tokyo and Johns Hopkins University; and is reported this week in the online Early Edition of the Proceedings of the National Academy of Sciences.
NicOx S.A. announced the presentation of detailed 26-week efficacy, safety and tolerability data from the second pivotal phase 3 study for naproxcinod (the 302 study) yesterday, at the American College of Rheumatology (ACR) and Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting in Philadelphia, Pennsylvania.
Novimmune SA announces that patients diagnosed with hemophagocytic lymphohistiocytosis (HLH), and who are participating in the company's ongoing clinical trial of its NI-0501 monoclonal antibody, will now be able to be treated with the drug without having to first fail conventional treatments.
Dizziness is one of the most common medical complaints affecting older adults, with 10-20 percent of such complaints resulting from Benign Paroxysmal Positional Vertigo (BPPV). Many research studies have stated that without medical treatment, some 30 percent of BPPV patients will recover on their own. Now, a new evidence-based review has found that a single ten minute in-office treatment, based on a series of head and body turns, is highly effective in resolving this disorder, with an overall effectiveness of 70-80 percent.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sajjad Minhas, MD 861 Sw 78th Ave, Suite # 100-b, Plantation, FL 33324-3273 Ph: (954) 693-0000 | Sajjad Minhas, MD 515 N Mesa Dr, Mesa, AZ 85201-5914 Ph: (480) 844-6285 |
News Archive
Scientists have identified a new, highly conserved molecular target on the influenza A virus and demonstrated that human antibodies against this target are protective in animal models of seasonal and highly-pathogenic avian influenza. The work was conducted by researchers at Theraclone Sciences, with collaborators at University of Wisconsin-Madison, University of Tokyo and Johns Hopkins University; and is reported this week in the online Early Edition of the Proceedings of the National Academy of Sciences.
NicOx S.A. announced the presentation of detailed 26-week efficacy, safety and tolerability data from the second pivotal phase 3 study for naproxcinod (the 302 study) yesterday, at the American College of Rheumatology (ACR) and Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting in Philadelphia, Pennsylvania.
Novimmune SA announces that patients diagnosed with hemophagocytic lymphohistiocytosis (HLH), and who are participating in the company's ongoing clinical trial of its NI-0501 monoclonal antibody, will now be able to be treated with the drug without having to first fail conventional treatments.
Dizziness is one of the most common medical complaints affecting older adults, with 10-20 percent of such complaints resulting from Benign Paroxysmal Positional Vertigo (BPPV). Many research studies have stated that without medical treatment, some 30 percent of BPPV patients will recover on their own. Now, a new evidence-based review has found that a single ten minute in-office treatment, based on a series of head and body turns, is highly effective in resolving this disorder, with an overall effectiveness of 70-80 percent.
› Verified 3 days ago
Dr. Ramona Beatrice Woodriffe, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4824 E Baseline Rd, Suite 110, Mesa, AZ 85206 Phone: 480-969-4040 Fax: 480-830-1042 | |
David E. Boesch, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 N Country Club Dr, Banner Mesa Medical Center, Mesa, AZ 85201 Phone: 480-834-1211 | |
Charles H Pshaenich, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1400 S Dobson Rd, Mesa, AZ 85202 Phone: 480-456-9500 Fax: 480-820-7623 | |
Richard Scholl, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1840 S Stapley Dr, Suite 101, Mesa, AZ 85204 Phone: 480-206-2424 | |
Joseph W Winchell, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Rd, Mesa, AZ 85202 Phone: 480-456-9500 Fax: 480-820-7623 | |
Diane L. Elmore, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 N Dobson Rd Ste 108, Mesa, AZ 85201 Phone: 480-456-9300 | |
Dr. Drummond Grant Vogan, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4850 E Baseline Rd Ste 107, Mesa, AZ 85206 Phone: 480-908-9892 Fax: 602-661-1189 |